医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2014年
8期
1569-1571
,共3页
高四红%郑桃林%何伟
高四紅%鄭桃林%何偉
고사홍%정도림%하위
绕丹宁/治疗应用%绕丹宁/类似物和衍生物%前列地尔/治疗应用%维生素B12/治疗应用%注射剂%药物疗法 ,联合%糖尿病神经病变/药物疗法%治疗结果
繞丹寧/治療應用%繞丹寧/類似物和衍生物%前列地爾/治療應用%維生素B12/治療應用%註射劑%藥物療法 ,聯閤%糖尿病神經病變/藥物療法%治療結果
요단저/치료응용%요단저/유사물화연생물%전렬지이/치료응용%유생소B12/치료응용%주사제%약물요법 ,연합%당뇨병신경병변/약물요법%치료결과
Rhodanine/TU%Rhodanine/AA%Alprostadil/TU%Vitamin B12/TU%INJECTIO%Drug Therapy,Combination%Diabetic Neuropathies/DT%Treatment Outcome
【目的】观察依帕司他联合前列地尔治疗糖尿病周围神经病变(DPN )的临床疗效。【方法】将88例2型糖尿病(T2DM )DPN的患者随机分为对照组与观察组,各44例,两组患者均严格控制饮食、适量运动、口服降糖药或注射胰岛素控制血糖,甲钴胺注射液0.5 mg肌注,每日1次。在此基础上,观察组加用依帕司他50 mg口服,每日3次;前列地尔20μg+0.9%氯化钠注射液100 m L静脉滴注,每日1次。疗程均为2周。【结果】观察组患者自觉症状改善总有效率(97.7%)显著高于对照组(72.7%)( P <0.05);两组神经传导速度(NCV)均明显改善,观察组优于对照组,差异具有统计学意义( P <0.01)。【结论】依帕司他、前列地尔及甲钴胺注射液联合治疗DPN效果显著。
【目的】觀察依帕司他聯閤前列地爾治療糖尿病週圍神經病變(DPN )的臨床療效。【方法】將88例2型糖尿病(T2DM )DPN的患者隨機分為對照組與觀察組,各44例,兩組患者均嚴格控製飲食、適量運動、口服降糖藥或註射胰島素控製血糖,甲鈷胺註射液0.5 mg肌註,每日1次。在此基礎上,觀察組加用依帕司他50 mg口服,每日3次;前列地爾20μg+0.9%氯化鈉註射液100 m L靜脈滴註,每日1次。療程均為2週。【結果】觀察組患者自覺癥狀改善總有效率(97.7%)顯著高于對照組(72.7%)( P <0.05);兩組神經傳導速度(NCV)均明顯改善,觀察組優于對照組,差異具有統計學意義( P <0.01)。【結論】依帕司他、前列地爾及甲鈷胺註射液聯閤治療DPN效果顯著。
【목적】관찰의파사타연합전렬지이치료당뇨병주위신경병변(DPN )적림상료효。【방법】장88례2형당뇨병(T2DM )DPN적환자수궤분위대조조여관찰조,각44례,량조환자균엄격공제음식、괄량운동、구복강당약혹주사이도소공제혈당,갑고알주사액0.5 mg기주,매일1차。재차기출상,관찰조가용의파사타50 mg구복,매일3차;전렬지이20μg+0.9%록화납주사액100 m L정맥적주,매일1차。료정균위2주。【결과】관찰조환자자각증상개선총유효솔(97.7%)현저고우대조조(72.7%)( P <0.05);량조신경전도속도(NCV)균명현개선,관찰조우우대조조,차이구유통계학의의( P <0.01)。【결론】의파사타、전렬지이급갑고알주사액연합치료DPN효과현저。
To observe clinical efficacy of epalrestat combined with alprostadil for the treatment of diabetic perineuropathy(DPN) .[Methods] Totally 88 patients with type 2 diabetes mellitus(T2DM) peripheral neuropathy were randomly divided into control group ( n =44) and observation group( n = 44) .Patients in two groups received strict diet control ,appropriate exercise ,oral blood glucose lowering drug or insulin injection to control blood glucose ,and also intramuscular injection with mecobalamin 0 .5mg once daily .On the basis of the treatment of the control group ,the observation group additionally received oral epalrestat 50mg 3 times per day and alprostadil 20 μg+ 0 .9% sodium chloride by intravenous injection once daily .The treatment course was 2 weeks .[Results] The total effective rate of the improvement of subjective symptoms in observation group (97 .7% ) was significantly higher than that in control group(72 .7% )( P<0 .05) .Motor nerve conduction velocity (MNCV) in two groups was obviously improved ,and the improvement in observation group was better than control group , and there was significant difference ( P < 0 .01) .[Conclusion] The combination of epalrestat ,alprostadil and mecobalamine injection is markedly effective in the treatment of DPN .